Literature DB >> 33466239

Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries.

Junjie Huang1, Anastasios Koulaouzidis2, Wojciech Marlicz3,4, Veeleah Lok5, Cedric Chu1, Chun Ho Ngai1, Lin Zhang6,7,8, Ping Chen9, Shanjuan Wang10, Jinqiu Yuan11, Xiang-Qian Lao1, Shelly L A Tse1, Wanghong Xu12, Zhi-Jie Zheng13, Shao-Hua Xie14, Martin C S Wong1,8,13.   

Abstract

This study aimed to examine the global burden, risk factors, and trends of esophageal cancer based on age, sex, and histological subtype. The data were retrieved from cancer registries database from 48 countries in the period 1980-2017. Temporal patterns of incidence and mortality were evaluated by average annual percent change (AAPC) using joinpoint regression. Associations with risk factors were examined by linear regression. The highest incidence of esophageal cancer was observed in Eastern Asia. The highest incidence of adenocarcinoma (AC) was found in the Netherlands, the United Kingdom, and Ireland. A higher AC/squamous cell carcinoma (SCC) incidence ratio was associated with a higher prevalence of obesity and elevated cholesterol. We observed an incidence increase (including AC and SCC) in some countries, with the Czech Republic (female: AAPC 4.66), Spain (female: 3.41), Norway (male: 3.10), Japan (female: 2.18), Thailand (male: 2.17), the Netherlands (male: 2.11; female: 1.88), and Canada (male: 1.51) showing the most significant increase. Countries with increasing mortality included Thailand (male: 5.24), Austria (female: 3.67), Latvia (male: 2.33), and Portugal (male: 1.12). Although the incidence of esophageal cancer showed an overall decreasing trend, an increasing trend was observed in some countries with high AC/SCC incidence ratios. More preventive measures are needed for these countries.

Entities:  

Keywords:  esophageal cancer; histological subtypes; incidence; mortality; risk factors

Year:  2021        PMID: 33466239      PMCID: PMC7795486          DOI: 10.3390/cancers13010141

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  51 in total

1.  The Global Burden of Cancer 2013.

Authors:  Christina Fitzmaurice; Daniel Dicker; Amanda Pain; Hannah Hamavid; Maziar Moradi-Lakeh; Michael F MacIntyre; Christine Allen; Gillian Hansen; Rachel Woodbrook; Charles Wolfe; Randah R Hamadeh; Ami Moore; Andrea Werdecker; Bradford D Gessner; Braden Te Ao; Brian McMahon; Chante Karimkhani; Chuanhua Yu; Graham S Cooke; David C Schwebel; David O Carpenter; David M Pereira; Denis Nash; Dhruv S Kazi; Diego De Leo; Dietrich Plass; Kingsley N Ukwaja; George D Thurston; Kim Yun Jin; Edgar P Simard; Edward Mills; Eun-Kee Park; Ferrán Catalá-López; Gabrielle deVeber; Carolyn Gotay; Gulfaraz Khan; H Dean Hosgood; Itamar S Santos; Janet L Leasher; Jasvinder Singh; James Leigh; Jost B Jonas; Jost Jonas; Juan Sanabria; Justin Beardsley; Kathryn H Jacobsen; Ken Takahashi; Richard C Franklin; Luca Ronfani; Marcella Montico; Luigi Naldi; Marcello Tonelli; Johanna Geleijnse; Max Petzold; Mark G Shrime; Mustafa Younis; Naohiro Yonemoto; Nicholas Breitborde; Paul Yip; Farshad Pourmalek; Paulo A Lotufo; Alireza Esteghamati; Graeme J Hankey; Raghib Ali; Raimundas Lunevicius; Reza Malekzadeh; Robert Dellavalle; Robert Weintraub; Robyn Lucas; Roderick Hay; David Rojas-Rueda; Ronny Westerman; Sadaf G Sepanlou; Sandra Nolte; Scott Patten; Scott Weichenthal; Semaw Ferede Abera; Seyed-Mohammad Fereshtehnejad; Ivy Shiue; Tim Driscoll; Tommi Vasankari; Ubai Alsharif; Vafa Rahimi-Movaghar; Vasiliy V Vlassov; W S Marcenes; Wubegzier Mekonnen; Yohannes Adama Melaku; Yuichiro Yano; Al Artaman; Ismael Campos; Jennifer MacLachlan; Ulrich Mueller; Daniel Kim; Matias Trillini; Babak Eshrati; Hywel C Williams; Kenji Shibuya; Rakhi Dandona; Kinnari Murthy; Benjamin Cowie; Azmeraw T Amare; Carl Abelardo Antonio; Carlos Castañeda-Orjuela; Coen H van Gool; Francesco Violante; In-Hwan Oh; Kedede Deribe; Kjetil Soreide; Luke Knibbs; Maia Kereselidze; Mark Green; Rosario Cardenas; Nobhojit Roy; Taavi Tillmann; Taavi Tillman; Yongmei Li; Hans Krueger; Lorenzo Monasta; Subhojit Dey; Sara Sheikhbahaei; Nima Hafezi-Nejad; G Anil Kumar; Chandrashekhar T Sreeramareddy; Lalit Dandona; Haidong Wang; Stein Emil Vollset; Ali Mokdad; Joshua A Salomon; Rafael Lozano; Theo Vos; Mohammad Forouzanfar; Alan Lopez; Christopher Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

Review 2.  The Male Predominance in Esophageal Adenocarcinoma.

Authors:  Shao-Hua Xie; Jesper Lagergren
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-17       Impact factor: 11.382

Review 3.  Risk factors for oesophageal cancer.

Authors:  Shao-Hua Xie; Jesper Lagergren
Journal:  Best Pract Res Clin Gastroenterol       Date:  2018-11-22       Impact factor: 3.043

4.  Sex differences in the proportion of esophageal squamous cell carcinoma cases attributable to tobacco smoking and alcohol consumption.

Authors:  Nirmala Pandeya; Catherine M Olsen; David C Whiteman
Journal:  Cancer Epidemiol       Date:  2013-07-02       Impact factor: 2.984

5.  Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia.

Authors:  Kenneth E L McColl; James J Going
Journal:  Gut       Date:  2010-03       Impact factor: 23.059

6.  Continuing rapid increase in esophageal adenocarcinoma in England and Wales.

Authors:  Côme Lepage; Bernard Rachet; Valérie Jooste; Jean Faivre; Michel P Coleman
Journal:  Am J Gastroenterol       Date:  2008-10-03       Impact factor: 10.864

7.  Helicobacter pylori: a poor man's gut pathogen?

Authors:  Mohammed Mahdy Khalifa; Radwa Raed Sharaf; Ramy Karam Aziz
Journal:  Gut Pathog       Date:  2010-03-31       Impact factor: 4.181

8.  Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location.

Authors:  Martin C S Wong; Junjie Huang; Veeleah Lok; Jingxuan Wang; Franklin Fung; Hanyue Ding; Zhi-Jie Zheng
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-21       Impact factor: 11.382

9.  Global, regional and time-trend prevalence of central obesity: a systematic review and meta-analysis of 13.2 million subjects.

Authors:  Martin C S Wong; Junjie Huang; Jingxuan Wang; Paul S F Chan; Veeleah Lok; Xiao Chen; Colette Leung; Harry H X Wang; Xiang Qian Lao; Zhi-Jie Zheng
Journal:  Eur J Epidemiol       Date:  2020-05-24       Impact factor: 8.082

Review 10.  Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy.

Authors:  Massimiliano di Pietro; Marcia I Canto; Rebecca C Fitzgerald
Journal:  Gastroenterology       Date:  2017-08-02       Impact factor: 22.682

View more
  16 in total

Review 1.  Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers.

Authors:  Natalie To; Richard P T Evans; Hayden Pearce; Sivesh K Kamarajah; Paul Moss; Ewen A Griffiths
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

2.  TM4SF1 promotes esophageal squamous cell carcinoma metastasis by interacting with integrin α6.

Authors:  Sicong Hou; Xin Hao; Jiajia Li; Siwei Weng; Jiaxin Wang; Tiantian Zhao; Wenqian Li; Xiaolin Hu; Bing Deng; Jianguo Gu; Qinglei Hang
Journal:  Cell Death Dis       Date:  2022-07-14       Impact factor: 9.685

3.  Survival Prediction Model for Patients with Esophageal Squamous Cell Carcinoma Based on the Parameter-Optimized Deep Belief Network Using the Improved Archimedes Optimization Algorithm.

Authors:  Yanfeng Wang; Wenhao Zhang; Junwei Sun; Lidong Wang; Xin Song; Xueke Zhao
Journal:  Comput Math Methods Med       Date:  2022-07-08       Impact factor: 2.809

4.  Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.

Authors:  Shao-Hua Xie; Giola Santoni; Jesper Lagergren
Journal:  Br J Cancer       Date:  2021-10-20       Impact factor: 9.075

5.  Current Role of Immunotherapy in Gastric, Esophageal and Gastro-Esophageal Junction Cancers-A Report from the Western Canadian Gastrointestinal Cancer Consensus Conference.

Authors:  Karen Mulder; Howard Lim; Deepti Ravi; Shahida Ahmed; Bryan Brunet; Janine Davies; Corinne Doll; Dorie-Anna Dueck; Vallerie Gordon; Pamela Hebbard; Christina A Kim; Duc Le; Richard Lee-Ying; John Paul McGhie; Jason Park; Daniel J Renouf; Devin Schellenberg; Ralph P W Wong; Adnan Zaidi; Shahid Ahmed
Journal:  Curr Oncol       Date:  2022-04-29       Impact factor: 3.109

6.  Endoscopic Submucosal Dissection vs. Surgery for Superficial Esophageal Squamous Cancer: A Systematic Review and Meta-Analysis.

Authors:  Zhifeng Liu; Renping Zhao
Journal:  Front Oncol       Date:  2022-04-21       Impact factor: 5.738

7.  Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A.

Authors:  Zhuo Bao; Ang Li; Xuebo Lu; Zitong Wang; Yin Yu; Wenjie Wu; Lili Zhao; Bo Li; Xiangyu Wu; Kyle Vaughn Laster; Chengjuan Zhang; Yanan Jiang; Zigang Dong; Kangdong Liu
Journal:  Cell Death Dis       Date:  2022-02-25       Impact factor: 8.469

Review 8.  Role of Obesity, Physical Exercise, Adipose Tissue-Skeletal Muscle Crosstalk and Molecular Advances in Barrett's Esophagus and Esophageal Adenocarcinoma.

Authors:  Jan Bilski; Monika Pinkas; Dagmara Wojcik-Grzybek; Marcin Magierowski; Edyta Korbut; Agnieszka Mazur-Bialy; Gracjana Krzysiek-Maczka; Slawomir Kwiecien; Katarzyna Magierowska; Tomasz Brzozowski
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

9.  Dietary fatty acid patterns and risk of oesophageal squamous cell carcinoma.

Authors:  Chanchan Hu; Zheng Lin; Zhiqiang Liu; Xuwei Tang; Jianyu Song; Jianbo Lin; Yuanmei Chen; Zhijian Hu
Journal:  PeerJ       Date:  2022-03-31       Impact factor: 2.984

10.  Association of Metabolic Parameter Variability with Esophageal Cancer Risk: A Nationwide Population-Based Study.

Authors:  Ji Eun Lee; Kyungdo Han; Juhwan Yoo; Yohwan Yeo; In Young Cho; Belong Cho; Hyuktae Kwon; Dong Wook Shin; Jong Ho Cho; Yong-Moon Park
Journal:  J Pers Med       Date:  2022-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.